Zobrazeno 1 - 10
of 192
pro vyhledávání: '"Sheila G. Haworth"'
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 6 (2023)
Background Transthoracic echocardiography is part of the regular follow‐up protocol at most pediatric pulmonary arterial hypertension (PAH) centers. We aimed to develop a comprehensive and simple echocardiographic risk stratification for children w
Externí odkaz:
https://doaj.org/article/e1a9f707a10f4444a277e50c74d6e48e
Autor:
María Jesús del Cerro, Steven Abman, Gabriel Díaz, Alexandra Heath Freudenthal, Franz Freudenthal, S. Harikrishnan, Sheila G. Haworth, Dunbar Ivy, Antonio A. Lopes, J. Usha Raj, Julio Sandoval, Kurt Stenmark, Ian Adatia
Publikováno v:
Revista Colombiana de Cardiología, Vol 19, Iss 6, Pp 339-352 (2012)
Las clasificaciones actuales de la hipertensión pulmonar han contribuido significativamente al conocimiento de la enfermedad vascular pulmonar, han facilitado ensayos farmacológicos y han mejorado nuestro conocimiento de las cardiopatías congénit
Externí odkaz:
https://doaj.org/article/e91d1ecd6d43482f9ddf8c8f683beeb8
Autor:
Astrid E. Lammers, Ian Adatia, María Jesús del Cerro, Gabriel Díaz, Alexandra Heath Freudenthal, Franz Freudenthal, S. Harikrishnan, Dunbar Ivy, Antonio A. Lopes, J. Usha Raj, Julio Sandoval, Kurt Stenmark, Sheila G. Haworth
Publikováno v:
Revista Colombiana de Cardiología, Vol 19, Iss 6, Pp 332-338 (2012)
Los miembros del Task Force pediátrico del Pulmonary Vascular Research Institute (PVRI, su sigla en Inglés) fueron conscientes de la necesidad de desarrollar una clasificación funcional de la hipertensión pulmonar en niños. La clasificación que
Externí odkaz:
https://doaj.org/article/8eb21e36bf1c429883f72665f61fdf4b
Autor:
Andrew Constantine, Konstantinos Dimopoulos, Sheila G. Haworth, Vivek Muthurangu, Shahin Moledina
Publikováno v:
American journal of respiratory and critical care medicine. 206(6)
Rationale: Pediatric pulmonary hypertension is an important cause of childhood morbidity and mortality, but there are limited data on the range of associated diseases, contributions of different pulmonary hypertension subtypes, therapeutic strategies
Autor:
Sheila G. Haworth, Paul Clift, Robin Condliffe, G Chaplin, Andrew Constantine, Konstantinos Dimopoulos, Vivek Muthurangu, Shahin Moledina
Publikováno v:
European Heart Journal. 42
Background/Introduction Pulmonary arterial hypertension (PAH) is a common complication of congenital heart disease (CHD) in children and is associated with significant morbidity and mortality. The impact of different phenotypes on management and surv
Publikováno v:
The Lancet Respiratory Medicine. 6:577-579
Autor:
D. Dunbar Ivy, Erika B. Rosenzweig, Rolf M. F. Berger, Sheila G. Haworth, Damien Bonnet, Ian Adatia, Maurice Beghetti, Steven H. Abman
Publikováno v:
The European Respiratory Journal
European Respiratory Journal, 53(1):1801916. EUROPEAN RESPIRATORY SOC JOURNALS LTD
European Respiratory Journal, Vol. 53, No 1 (2019) P. 1801916
European Respiratory Journal, 53(1):1801916. EUROPEAN RESPIRATORY SOC JOURNALS LTD
European Respiratory Journal, Vol. 53, No 1 (2019) P. 1801916
Paediatric pulmonary arterial hypertension (PAH) shares common features of adult disease, but is associated with several additional disorders and challenges that require unique approaches. This article discusses recent advances, ongoing challenges an
Autor:
Hanaa Banjar, D. Dunbar Ivy, Shahin Moledina, Goverdhan Dutt Puri, Omar Tamimi, Tilman Humpl, Sivadasanpillai Harikrishnan, Alexandria Heath-Freudenthal, Patience Udo, Lina Caicedo, Maha Al Dabbagh, Antonio Augusto Lopes, B. Rossouw, Sheila G. Haworth, Ana Olga Mocumbi, María Jesús del Cerro, Snehal Kulkarni, Gabriel Díaz, Anita Saxena, Ahmed Nasser Galal, Ian Adatia
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Cardiac catheterization is important in the diagnosis and risk stratification of pulmonary hypertensive vascular disease (PHVD) in children. Acute vasoreactivity testing provides key information about management, prognosis, therapeutic strategies, an
Autor:
Maurice Beghetti, Alain Fraisse, Oliver Miera, Rolf M. F. Berger, Damien Bonnet, Xavier Jaïs, Michela Efficace, Yves Dulac, Andjela Kusic-Pajic, Erika B. Rosenzweig, D. Dunbar Ivy, Sheila G. Haworth, Nazzareno Galiè
Publikováno v:
International Journal of Cardiology, 202, 52-58. ELSEVIER IRELAND LTD
International Journal of Cardiology, Vol. 202 (2016) pp. 52-8
International Journal of Cardiology, Vol. 202 (2016) pp. 52-8
A novel formulation of bosentan was evaluated in children with pulmonary arterial hypertension (PAH) in FUTURE-1, which characterized its pharmacokinetic and clinical profile. The subsequent phase III, open-label, long-term extension study, FUTURE-2,
Autor:
Bejal Pandya, Merlin R. McMillan, Sheila G. Haworth, Kristian H. Mortensen, Vivek Muthurangu, Margarita Bartsota, Shahin Moledina, Andrew M. Taylor, Sadia Quyam, Ingram Schulze-Neick
Publikováno v:
Circulation: Cardiovascular Imaging. 6:407-414
Background— There are very few validated prognostic markers in pediatric pulmonary hypertension. Cardiac MRI is a useful, noninvasive method for determining prognosis in adults. The present study is the first to assess its prognostic value in child